Ofloxacin is contraindicated in case of G6PD deficiency: Is it evidenced based?

被引：5

作者：

Carmoi, T. ^{[1
]}

Bordier, L. ^{[2
]}

Bonnefoy, S. ^{[1
]}

Callot, D. ^{[3
]}

Lecoules, S. ^{[1
]}

Algayres, J. -P. ^{[1
]}

机构：

[1] HIA Val de Grace, Serv Med Interne, F-75005 Paris, France

[2] HIA Begin, Serv Endocrinol, F-94163 St Mande, France

[3] Hop La Pitie Salpetriere, Serv Pharmacovigilance, F-75013 Paris, France

来源：

REVUE DE MEDECINE INTERNE | 2009年 / 30卷 / 04期

关键词：

G6PD deficiency; haemolysis; fluoroquinolones; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY;

D O I：

10.1016/j.revmed.2008.07.007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

G6PD deficiency is very frequent with almost 400 millions of patients worldwide in Asia, Africa and Mediterranean. G6PD deficiency is involved in mild or severe haemolysis and the precipitating factor is usually a drug. More than 100 drugs have been implicated and fluoroquinolones are one of the more classic. However, the literature review shows that only a few observations have been clearly documented. (C) 2008 Elsevier Masson SAS. Tous droits reserves.

引用

页码：355 / 357

页数：3